Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03216200 · ClinicalTrials.gov registry record · NA
Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
A NA study, sponsored by DeviceFarm.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03216200 is a NA study that has completed, run by DeviceFarm. The registered enrollment target is 5 participants.
The verdict
NCT03216200, a NA study, has completed, sponsored by DeviceFarm.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
A study to determine if a three-treatment protocol with the RenewalNail™ plasma treatment system over a week will result in mycological cure and/or clear nail growth on the treated hallux toe.
Interventions
- DEVICE plasma treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-07-07 |
| Est. Completion | 2018-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03216200
The ClinicalTrials.gov registry entry for NCT03216200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeviceFarm, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which plasma treatment is the first listed.
NCT03216200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03216200 about?
NCT03216200 is a clinical study titled "Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)". A study to determine if a three-treatment protocol with the RenewalNail™ plasma treatment system over a week will result in mycological cure and/or clear nail growth on the treated hallux toe.
What is the current status of trial NCT03216200?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2017-07-07. Estimated completion is 2018-07-10.
What interventions are being tested in trial NCT03216200?
The interventions under investigation include: plasma treatment (DEVICE).
Who is sponsoring clinical trial NCT03216200?
This trial is sponsored by DeviceFarm, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.